Jeff N. Tinianow

682 total citations
14 papers, 492 citations indexed

About

Jeff N. Tinianow is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Molecular Biology. According to data from OpenAlex, Jeff N. Tinianow has authored 14 papers receiving a total of 492 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Radiology, Nuclear Medicine and Imaging, 5 papers in Oncology and 4 papers in Molecular Biology. Recurrent topics in Jeff N. Tinianow's work include Radiopharmaceutical Chemistry and Applications (3 papers), HER2/EGFR in Cancer Research (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Jeff N. Tinianow is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (3 papers), HER2/EGFR in Cancer Research (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Jeff N. Tinianow collaborates with scholars based in United States, France and Netherlands. Jeff N. Tinianow's co-authors include Jan Mařı́k, Annie Ogasawara, Herman Gill, Alexander Vanderbilt, Judith E. Flores, Simon‐Peter Williams, Richard Vandlen, Elizabeth Luis, Martine Darwish and Jagath R. Junutula and has published in prestigious journals such as Analytical Biochemistry, Journal of Medicinal Chemistry and Journal of Cerebral Blood Flow & Metabolism.

In The Last Decade

Jeff N. Tinianow

14 papers receiving 484 citations

Peers

Countries citing papers authored by Jeff N. Tinianow

Since Specialization

Citations

This map shows the geographic impact of Jeff N. Tinianow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeff N. Tinianow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeff N. Tinianow more than expected).

Fields of papers citing papers by Jeff N. Tinianow

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeff N. Tinianow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeff N. Tinianow. The network helps show where Jeff N. Tinianow may publish in the future.

Co-authorship network of co-authors of Jeff N. Tinianow

This figure shows the co-authorship network connecting the top 25 collaborators of Jeff N. Tinianow. A scholar is included among the top collaborators of Jeff N. Tinianow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeff N. Tinianow. Jeff N. Tinianow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	GTP1 metabolic stability assessment: A study of the tau PET tracer [18F]GTP1 2023 ·Nuclear Medicine and Biology ·Jan Mařı́k, (unknown), Gauri Deshmukh, Donglu Zhang, Jeff N. Tinianow, Jingwei Cai, Susan Wong, Sudheer Bobba, Kevin DeMent, Ning Liu, Jason Halladay, Sandra Sanabria Bohórquez, Lionel Cheruzel, S. Cyrus Khojasteh	1
2	[18F]GTP1 (Genentech Tau Probe 1), a radioligand for detecting neurofibrillary tangle tau pathology in Alzheimer’s disease 2019 ·European Journal of Nuclear Medicine and Molecular Imaging ·Sandra Sanabria Bohórquez, Jan Mařı́k, Annie Ogasawara, Jeff N. Tinianow, Herman Gill, Olivier Barret, Gilles Tamagnan, David Alagille, Gai Ayalon, Paul T. Manser, Thomas Bengtsson, Michael E. Ward, Simon‐Peter Williams, Geoffrey A. Kerchner, John Seibyl, Kenneth Marek, Robby M. Weimer	82
3	Preparation and evaluation of L- and D-5-[ 18 F]fluorotryptophan as PET imaging probes for indoleamine and tryptophan 2,3-dioxygenases 2017 ·Nuclear Medicine and Biology ·Tang Tang, Herman Gill, Annie Ogasawara, Jeff N. Tinianow, Alexander Vanderbilt, Simon‐Peter Williams, Georgia Hatzivassiliou, (unknown), Wendy Sandoval, Kevin DeMent, Mengling Wong, Jan Mařı́k	19
4	Preclinical Efficacy of an Antibody–Drug Conjugate Targeting Mesothelin Correlates with Quantitative 89Zr-ImmunoPET 2016 ·Molecular Cancer Therapeutics ·Anton G.T. Terwisscha van Scheltinga, Annie Ogasawara, Glenn Pacheco, Alexander Vanderbilt, Jeff N. Tinianow, Nidhi Gupta, Dongwei Li, Ron Firestein, Jan Mařı́k, Suzie J. Scales, Simon‐Peter Williams	33
5	Evaluation of a 3-hydroxypyridin-2-one (2,3-HOPO) Based Macrocyclic Chelator for ⁸⁹Zr⁴⁺ and Its Use for ImmunoPET Imaging of HER2 Positive Model of Ovarian Carcinoma in Mice 2016 ·Theranostics ·Jeff N. Tinianow, Darpan N. Pandya, S. Pailloux, Annie Ogasawara, Alexander Vanderbilt, Herman Gill, (unknown), Thaddeus J. Wadas, Darren Magda, Jan Mařı́k	47
6	ImmunoPET helps predicting the efficacy of antibody-drug conjugates targeting TENB2 and STEAP1 2016 ·Oncotarget ·Simon‐Peter Williams, Annie Ogasawara, Jeff N. Tinianow, Judith E. Flores, David Kan, Jeffrey Lau, (unknown), Alexander Vanderbilt, Herman Gill, Miao Li, Joshua Goldsmith, Bonnee Rubinfeld, Weiguang Mao, Ron Firestein, Shang‐Fan Yu, Jan Mařı́k, Anton G.T. Terwisscha van Scheltinga	25
7	Evaluation of 2-[¹⁸F]fluoroacetate Kinetics in Rodent Models of Cerebral Hypoxia–Ischemia 2014 ·Journal of Cerebral Blood Flow & Metabolism ·(unknown), Jeff N. Tinianow, Simon R. Cherry, Jan Mařı́k	8
8	ImmunoPET imaging of phosphatidylserine in pro-apoptotic therapy treated tumor models 2012 ·Nuclear Medicine and Biology ·Annie Ogasawara, Jeff N. Tinianow, Alexander Vanderbilt, Herman Gill, Sharon Yee, Judith E. Flores, Simon‐Peter Williams, Avi Ashkenazi, Jan Mařı́k	18
9	Immuno-PET of the Hepatocyte Growth Factor Receptor Met Using the 1-Armed Antibody Onartuzumab 2012 ·Journal of Nuclear Medicine ·Elaine M. Jagoda, Lixin Lang, B. Veerendra, Stephanie Histed, Mark R. Williams, Gabriela Krämer-Marek, Esther Mena, Lauren Rosenblum, Jan Mařı́k, Jeff N. Tinianow, Mark Merchant, Lawrence P. Szajek, Chang H. Paik, Franco Cecchi, (unknown), (unknown), Donald P. Bottaro, Peter L. Choyke	52
10	The Development of Peptide-Based Tools for the Analysis of Angiogenesis 2011 ·Chemistry & Biology ·(unknown), Kerry Zobel, Herman Gill, Annie Ogasawara, Judith E. Flores, Jeff N. Tinianow, Alexander Vanderbilt, Ping Wu, Y. Gloria Meng, (unknown), Christian Wiesmann, Jeremy Murray, Jan Mařı́k, Kurt Deshayes	34
11	Site-specifically 89Zr-labeled monoclonal antibodies for ImmunoPET 2010 ·Nuclear Medicine and Biology ·Jeff N. Tinianow, Herman Gill, Annie Ogasawara, Judith E. Flores, Alexander Vanderbilt, Elizabeth Luis, Richard Vandlen, Martine Darwish, Jagath R. Junutula, (unknown), Jan Mařı́k	90
12	PET of Glial Metabolism Using 2-¹⁸F-Fluoroacetate 2009 ·Journal of Nuclear Medicine ·Jan Mařı́k, Annie Ogasawara, Baby Martin-McNulty, Jed Ross, Judith E. Flores, Herman Gill, Jeff N. Tinianow, Alexander Vanderbilt, Merry Nishimura, Franklin Peale, Cinthia V. Pastuskovas, Joan M. Greve, Nicholas van Bruggen, Simon P. Williams	35
13	A Modular Platform for the Rapid Site-Specific Radiolabeling of Proteins with ¹⁸F Exemplified by Quantitative Positron Emission Tomography of Human Epidermal Growth Factor Receptor 2 2009 ·Journal of Medicinal Chemistry ·Herman Gill, Jeff N. Tinianow, Annie Ogasawara, Judith E. Flores, Alexander Vanderbilt, Helga Raab, Justin M. Scheer, Richard Vandlen, (unknown), Jan Mařı́k	41
14	Development of a spectrophotometric assay for cyclase activity 2005 ·Analytical Biochemistry ·Eduardo Henrique Silva Sousa, (unknown), Jeff N. Tinianow, Nancy Counts Gerber	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact